Course Syllabus
- The History of GCP: Part 1
- The History of GCP: Part 2
- The History of GCP: Part 3
- The History of GCP: Part 4
- What is GCP?
- The Principles of ICaH GCP: Part 1
- The Principles of ICH GCP: Part 2
- Additional Learning Points
- Documentation and Version Control
- Quality Assurance (QA)
- Key Resources: Part 1
- Key Resources: Part 2
- Webinar: Introduction to GCP
- Introduction: Part 1
- Introduction: Part 2
- Introduction: Part 3
- Introduction: Part 4
- Introduction: Part 5
- Introduction: Part 6
- Introduction: Part 7
- Introduction: Part 8
- Introduction: Part 9
- Responsibilities of the CA
- Responsibilities of the IEC
- Subject Informed Consent Forms (ICF): Part 1
- Subject Informed Consent Forms (ICF): Part 2
- Composition, Functions, Operations, Procedures, and Records
- IEC Interactions with Sponsors and Investigators
- Introduction
- Investigator Responsibilities
- Investigator Qualifications and Agreements
- Adequate Resources
- Medical Care of Trial Subjects: Part 1
- Medical Care of Trial Subjects: Part 2
- Communication with IRB/IEC
- Compliance with the Protocol
- Investigational Medicinal Products
- Randomisation Procedures and Un-blinding
- Informed Consent: Introduction
- Informed Consent: The Consent Discussion
- Informed Consent: Subjects Who Cannot Read or Write
- Informed Consent: Minors and “Mentally Incompetent” Subjects
- Informed Consent: Incapacitated Subjects
- Informed Consent: Updating Consent
- Records and Reports: Introduction
- Records and Reports: Study Site Files
- Records and Reports: Updates & Amendments
- Records and Reports: Source Documents
- Records and Reports: Financial Information
- Records and Reports: The Case Record Form
- Records and Reports: Recording Subject Data
- Premature Termination or Suspension of a Trial
- Progress Reports and Final Reports by Investigator
- Investigator Responsibilities
- Introduction: Part 1
- Introduction: Part 2
- Introduction: Part 3
- Quality Management: Part 1
- Quality Management: Part 2
- Quality Management Part 3
- QA and QC (Quality Assurance and Quality Control): Introduction
- QA and QC (Quality Assurance and Quality Control): Standard Operating Procedures
- QA and QC (Quality Assurance and Quality Control): Agreements & Contracts
- Contract Research Organisations
- Trial Design
- Trial Management: Introduction
- Trial Management: Data Management
- Trial Management: Electronic Data
- Trial Management: Record Keeping
- Investigator Selection: Introduction
- Investigator Selection: Permissions
- Investigator Selection: Responsibilities
- Investigator Selection: Compensation
- Financing
- Notification/ Submission to Regulatory Authorities
- Gaining CA Approval in the EU: Part 1
- Gaining CA Approval in the EU: Part 2
- Confirmation of Review by IRB/IEC
- Information on IMP
- Manufacturing, Packaging, Labelling, and Coding Investigational Products: Part 1
- Manufacturing, Packaging, Labelling, and Coding Investigational Products: Part 2
- Supplying and Handling Investigational Products
- Record Access
- Audit and Inspection
- Noncompliance
- Premature Termination or Suspension of a Trial: Part 1
- Premature Termination or Suspension of a Trial: Part 2
- Clinical Trial/Study Reports
- Multicentre Trials
- Introduction
- Monitor
- The Monitoring Visit: Part 1
- The Monitoring Visit: Part 2
- Verifying IMP
- Complying with the Protocol, Amendments, SOP and Guidance
- Verifying Informed Consent
- The Case Record Form (CRF) and Source Documents
- Verifying Subject Data
- Closing out the Monitoring Visit
- The Monitoring Report & Plan
- Quality Management - Centralised Monitoring
- Fraud and Misconduct: Part 1
- Fraud and Misconduct: Part 2
- Introduction
- AEs, ADRs, & SUSARs
- Serious Adverse Events
- SUSARs
- Adverse Events of Special Interest
- Periodic Safety Reports
- Introduction
- Protocol Structure and Content: Part 1
- Protocol Structure and Content: Part 2
- Protocol Structure and Content: Part 3
- Introduction
- Investigator Brochure Structure and Content
- Introductions
- Archiving
- Documents to be Present Pre-Study
- Documents to be Present Post-Study
- Glossary & Abbreviations
- EU Guidance Documents
- ICH Guidance Documents
- US FDA Guidance Documents
- GCP Course Printouts
- Global Competent Authorities List
Our GCP certified customers
Good Clinical Practice (GCP) training is an essential educational program that equips researchers and clinical trial professionals with the knowledge of ethical and scientific standards crucial for conducting high-quality clinical trials. This comprehensive training covers the internationally recognized guidelines established by the International Council for Harmonisation (ICH).
The primary goals of GCP training are:
- Ensuring the protection of human subjects' rights, safety, and well-being
- Maintaining the integrity and reliability of clinical trial data
- Promoting consistent, high-quality practices across all aspects of clinical research
Our GCP course delves into these critical areas, providing learners with a solid foundation in the principles and practical applications of Good Clinical Practice.
For researchers interested in participating in clinical trials, GCP certification is a necessity.
For those who are simply interested in improving their understanding of the field, GCP certification is highly valuable due to its:
- Ensures compliance with international standards
- Enhances research credibility and quality
- Protects participant rights and safety
- Improves career prospects in clinical research
Our course not only provides certification but also equips you with practical skills to apply GCP principles effectively in your work.
GCP certification is essential for a wide range of professionals in clinical research:
- Clinical Trial Investigators: Principal investigators and sub-investigators responsible for trial conduct at research sites.
- Clinical Trial Staff: Including research coordinators, study nurses, and other site personnel involved in trial management.
- Sponsors and Contract Research Organizations (CROs): Those overseeing trial planning, initiation, and reporting.
- Regulatory Authorities: Officials who monitor and evaluate trial compliance.
- Institutional Review Boards (IRBs) and Ethics Committees: Members reviewing and approving trial protocols.
- Academic and Research Institution Staff: Ensuring adherence to international standards in institutional research.
- NIH-Funded Researchers: All investigators and staff involved in NIH-funded clinical trials.
Our course caters to this diverse audience, providing role-specific insights alongside core GCP principles. The course is also valuable for anyone looking to upskill their research abilities and improve their clinical trials operations.
This GCP training course covers the ICH-GCP (E6-R2) international guidelines and meets the training requirement for you to participate in international clinical trials. Multiple language versions are available. This GCP training course is a step-by-step and up-to-date guide to the international ICH-GCP (E6-R2) guidelines. It is essential for anyone taking part in the running of a clinical trial.
The course was written by an expert with over 30 years of experience up to the Research Director level in a major pharma group. Our ICH GCP training is accepted worldwide as it meets the TransCelerate Biopharma mutual recognition criteria. Also, it is accredited by the Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. Apart from English, the course is available in German, Bulgarian, French, Italian, Japanese, Polish, Portuguese, Russian and Spanish. We also produce regional versions of this course tailored to the specific regulatory frameworks in Australia, the UK, the US, France, Germany and Latin America.
This course features a clear and visually appealing format, allowing for easy cross-referencing to the ICH-GCP E6 document. It offers valuable insights into the practical application of Good Clinical Practice (GCP) based on the author's extensive experience. Furthermore, it is accredited by the Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom and provides participants with the opportunity to earn 6 CPD points.
Yes, our GCP course is accredited by two industry-leading organisations:
- TransCelerate Biopharma Inc.: A nonprofit organisation collaborating with 20 major pharmaceutical companies. Their mutual recognition program is considered the gold standard in the field of clinical practice.
- The Faculty of Pharmaceutical Medicine at the Royal College of Physicians: The professional membership body for pharmaceutical physicians in the UK, known for setting rigorous standards for research since 1989.
These accreditations ensure our course meets the highest industry and academic standards, offering you a widely recognized certification.
Costs vary depending on the following factors:
- Accreditation: Is the course approved by official organisations, like TransCelerate?)
- Certification: Does the course meet the ICH requirements that allows researchers to participate in international clinical trials?
- Quality of content: Is the course up-to-date, and written by an expert?
- Access: How long are learners able to access the course?
Whitehall Training’s GCP course is £79 due to its:
- Accreditation: It is TransCelerate approved, and accredited by the Royal College of Physicians with 6 CPD points.
- Certification: The course enables users to participate in clinical trials, following the ICH E6(R2) guidelines.
- Quality of content: Our course is written by our Good Clinical Practice expert, Lucy Parker, who has over a decade of experience directing research across large research institutes such as the NHS.
- Access: To support the lifelong learning of our researchers, we provide lifetime access to our course resources.
Buying for a team? We offer 10% off orders of 5 licences at checkout. For discounts on larger orders, please get in touch with our team.
While some free GCP training options do exist, they often have these limitations:
- Low quality (not accredited) and out-of-date content
- No official certification provided, which means researchers are still not able to conduct clinical research
These courses can, however, provide a basic understanding of the principles for those who are just looking for an introduction to Good Clinical Practice and its concepts.
Our comprehensive GCP training program is designed to provide a thorough understanding of the principles and practices essential for conducting ethical, scientifically sound clinical trials. The course structure includes both foundational and advanced modules, ensuring that learners at all levels can benefit from the content.
Key topics covered in the course include:
- History and principles of GCP
- Roles and responsibilities of investigators, sponsors, and monitors
- Ethical considerations and informed consent processes
- Protocol design and adherence
- Safety reporting and adverse event management
- Data integrity and quality management
Our GCP course is designed to ensure that participants not only learn the material but can also apply it effectively in real-world clinical research settings. To this end, the course incorporates various assessment methods throughout:
Ongoing Assessments: Throughout the modules, learners engage with interactive quizzes and case-based scenarios. These help reinforce key concepts and allow participants to gauge their understanding as they progress.
Final Comprehensive Exam: The course culminates in a final exam that thoroughly assesses the learner's grasp of GCP principles and practices. This exam covers all major topics from the course, including:
Ethical considerations in clinical research
Regulatory requirements and compliance
Roles and responsibilities in clinical trials
Data integrity and quality management
Safety reporting and adverse event handling
Practical Application: Some questions in the final exam are designed to test the learner's ability to apply GCP principles to realistic clinical trial scenarios.
To ensure learners are fully prepared to conduct their trials, successful completion of the final exam is required to obtain GCP certification.
The final exam may be taken an unlimited amount of times, ensuring that learner reach this level and, thereby, become GCP qualified.
Our course is designed to benefit a wide range of professionals involved in clinical research. While a basic understanding of clinical research is helpful, it's not a prerequisite. The course content is carefully structured to accommodate various levels of experience and roles within the clinical trial landscape.
This training is particularly valuable for:
Clinical Research Coordinators
Principal Investigators and Sub-Investigators
Research Nurses
Clinical Trial Managers
Data Managers and Biostatisticians
Regulatory Affairs Professionals
Quality Assurance Specialists
Ethics Committee Members
Pharmacists involved in clinical trials
Sponsors and CRO personnel
Whether you're new to clinical research or looking to refresh and update your knowledge, this course provides comprehensive coverage of GCP principles and their practical application.
Our GCP course is delivered entirely online, offering maximum flexibility and accessibility for learners. This format has several advantages:
Self-paced learning: Participants can progress through the course materials at a pace that suits their individual learning style and schedule. This allows for a deeper engagement with the content without the pressure of keeping up with a classroom.
Convenient access: The course is accessible 24/7 from any device with an internet connection. This means you can learn from your office, home, or while traveling.
ICH is a global initiative that develops guidelines for pharmaceutical research and development, including Good Clinical Practice (GCP). Key points:
ICH brings together regulatory authorities and industry representatives.
It creates internationally recognized standards for clinical trials.
ICH GCP guidelines focus on protecting participants and ensuring data integrity.
These guidelines are periodically updated, with ICH GCP E6(R2) being the latest version.
In order to conduct compliant clinical trials, these ICH guidelines must be adhered to. That’s why we made this course, covering all of the 13 core ICH GCP principles thoroughly, preparing you to conduct research that meets global standards.
ICH Good Clinical Practice E6 (R2) refers to the most recent revision of the Good Clinical Practice guidelines issued by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). This update, released in 2016, represents a significant evolution in GCP standards, reflecting the changing landscape of clinical research.
Understanding ICH GCP E6 (R2) is crucial for anyone involved in clinical research because:
It represents the current global standard for conducting ethical and scientifically sound clinical trials.
Compliance with these guidelines is often required by regulatory authorities worldwide.
It helps ensure the protection of human subjects and the reliability of trial data.
Many sponsors and research organisations expect their staff and partners to be familiar with and adhere to these updated guidelines.
Our GCP course thoroughly covers ICH GCP E6 (R2), ensuring that participants understand these updated guidelines and can apply them effectively in their clinical research activities.
ICH GCP is built on 13 key principles that guide ethical and scientific standards in clinical research. These include:
Ethical conduct
Benefits outweighing risks
Participant rights and safety
Adequate supporting data
Scientifically sound protocols
IRB/IEC approval
Qualified medical supervision
Qualified investigators
Informed consent
Accurate data recording and reporting
Confidentiality
Good manufacturing practices for investigational products
Quality assurance systems
Our course provides in-depth coverage of these principles, ensuring you understand how to apply them in real-world clinical research settings.